DOI: 10.21045/2071-5021-2017-53-1-11
Punga VV.1, Tsybikova E.B.2, Yakimova M.A.1, Izmaylova T.V.1
1Central Research TB Institute, Moscow
2Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation, Moscow
Contacts: Erzheny Tsybikova, e-mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Information about authors:
Punga V.V., http://orcid.org/0000-0003-0564-2099
Tsybikova E.B., http://orcid.org/0000-0002-9131-3584
Yakimova M.A., http://orcid.org/0000-0002-3892-6402
Izmailova T.V., http://orcid.org/0000-0002-4197-355Õ
Acknowledgments.The study had no sponsorship.
Conflct of interests. The authors declare no conflict of interest.
Abstract. Significance. Currently Russia reports a high
prevalence of TB-HIV co-infection. The number of new TB-HIV cases
reached 16100 in 2015 or 19% of the total number of new TB cases.
Clinical progression of TB in HIV patients is characterized by rapid
progress and trend towards wide dissemination. Multidrug extensive drug
resistant Mycobacterium tuberculosis highly increases risk of mortality
among such patients. Cohort analysis makes it possible to objectively
estimate treatment results for TB-HIV patients and identify regions of
the Russian Federation with effective TB control.
The study purpose: to estimate treatment results for TB-HIV patients using cohort analysis data.
Materials and methods. TB and HIV indicators for
2012-2015 calculated using reporting statistical forms #8 and #61 as
well as data from reporting forms according to the Ministry of Health
Order #50 on treatment results for 1354 TB-HIV patients in 2014 received
from 13 Russian regions.
Results: Cohort analysis of treatment results for newly
diagnosed patients with TB and HIV co-infection conducted in 13 Russian
regions showed that structure of treatment outcomes narrowed to only
three outcomes: effective - 47.2% of cases; deaths - 26.2% or over a
quarter of the total number of patients registered for treatment; and
ineffective - 16.1%. Other treatment outcomes (early treatment
termination, dropouts) hardly developed due to high mortality during the
first months in treatment.
Keywords: Lung TB; HIV; TB-HIV co-infection; cohort analysis; mortality.
References
-
Lechenie tuberkuleza: rekomendatsii. 4-e izd. [Tuberculosis treatment:
Manual. 4-nd ed.]. Geneva. WHO Regional Office for Europe. 2011. 183 p.
(In Russian).
-
Rukovodyashchie printsipy dlya intensivnogo vyyavleniya tuberkuleza i
profilakticheskoy terapii izoniazidom u lyudey, zhivushchikh s VICh, v
usloviyakh nekhvatki resursov [Guidelines on intensive tuberculosis
detection and izoniazid preventive therapy for people living with HIV in
resource-limited settings]. Geneva. WHO Regional Office for Europe;
2011. 39 p. [Online] [cited 2016 Oct 25]. Available from:
http://apps.who.int/iris/bitstream/10665/44472/3/9789244500705_rus.pdf.
(In Russian).
-
Tuberkulez: vyyavlenie, lechenie i monitoring po K. Tomenu. Voprosy i
otvety [Tuberculosis: detection, treatment and monitoring using K. Tomen
method. Questions and answers]. [Transl. from Eng.]. Moscow: Ves' mir.
2004. 387 p. (In Russian).
-
Tuberkulez v XXI veke: Problemy i puti resheniya [Tuberculosis in XXI
century: Challengers and solution]. Trudy FGBNU «Tsentral'nyy
nauchno-issledovatel'skiy institut tuberkuleza» Moscow: OOO
«Galleya-Print»; 2015. 5-19. (In Russian).
-
Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu
tuberkuleza u bol'nykh s VICh-infektsiey [Federal clinical
recommendations on tuberculosis diagnosis and treatment in HIV-infected
patients]. Moscow: Izdatel'stvo «Triada»; 2014. 54 p. (In Russian).
-
Tsybikova E.B., Sabgayda T.P. Epidemiologiya tuberkuleza, sochetannogo s
VICh-infektsiey [Epidemiology of tuberculosis co-infected with HIV]. Zdravookhranenie Rossiyskoy Federatsii 2012; (6): 7-11. (In Russian).
-
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Laloo U, et al.
Extensively drug resistant tuberculosis as a cause of death in patients
co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368 (9547): 1575-1580.
-
Guidelines for the programmatic management of drug-resistant
tuberculosis: emergency update 2008. Geneva: World Health Organization;
[Online] 2008 [cited 2017 Jun 25]. Available from: http://apps.who.int/iris/bitstream/10665/43965/1/9789241547581_eng.pdf
-
WHO Three I’s Meeting: Intensified case finding (ICF), Izoniazid
preventive therapy (IPT) and TB Infection control (IC) for people living
with HIV. [Online] [cited 2017 Jun 25]. Available from: http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_report.pdf?ua=1
Views: 10511
|